Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. Founded by Luis Diaz, Victor Velculescu, and Victor Velculescu in 2010, Personal Genome Diagnostics is backed by investors that include Kern Capital, New Enterprise Associates, Northpond Ventures, Rock Springs Capital, and Catalio Capital Management and is headquartered in Baltimore.